CareHub Dermatology Guide4 min read

Heart Failure

Clinical guidelines for managing reduced ejection fraction, fluid overload, and novel cardiac therapies.

OpenPHR Flagship Deep-Dive Product
Explore our Flagship Parkinson's Disease Hub (Live Clinical Trials, DBS & DaTscan Price Spreads & Medicare Guide)
Start with Parkinson's

🧠 Standard of Care

Heart Failure (HF) is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. It is broadly categorized into two types: Heart Failure with Reduced Ejection Fraction (HFrEF) and Heart Failure with Preserved Ejection Fraction (HFpEF).

  • Diagnosis: An echocardiogram is the gold standard for diagnosis. It measures the Ejection Fraction (EF), which dictates the treatment pathway. Elevated levels of brain natriuretic peptide (BNP) in the blood also strongly indicate heart failure.
  • Fluid Management: Because the heart isn't pumping effectively, fluid backs up into the lungs (causing shortness of breath) and the lower extremities (causing edema). Daily weight monitoring is critical to catch fluid retention early.
  • Lifestyle: Strict sodium restriction (often less than 2,000 mg/day) and fluid restriction are necessary to prevent dangerous fluid overload.

💊 Medical Therapies

Guideline-directed medical therapy (GDMT) for HFrEF is built upon four foundational "pillars" of medication that have been proven to reduce mortality and hospitalizations.

ARNI (Entresto)

Sacubitril/valsartan (Entresto) is a first-line therapy that combines an angiotensin receptor blocker with a neprilysin inhibitor, significantly reducing the risk of cardiovascular death compared to older ACE inhibitors.

Beta Blockers

Medications like carvedilol, metoprolol succinate, and bisoprolol slow the heart rate and lower blood pressure, allowing the heart to fill more completely and reducing the heart's workload.

SGLT2 Inhibitors

Originally developed for diabetes, drugs like dapagliflozin (Farxiga) and empagliflozin (Jardiance) are now a cornerstone of heart failure treatment, helping the kidneys remove excess sodium and glucose, which drastically improves HF outcomes.

Mineralocorticoid Receptor Antagonists (MRAs)

Spironolactone or eplerenone are weak diuretics but powerful anti-fibrotics that prevent harmful remodeling of the heart muscle.

🫀 Devices & Surgery

When medications are not enough, implantable devices can save lives and improve heart function.

  • ICD (Implantable Cardioverter-Defibrillator): Patients with very low ejection fractions are at high risk for sudden cardiac arrest. An ICD constantly monitors the heart rhythm and delivers a shock if a lethal arrhythmia occurs.
  • CRT (Cardiac Resynchronization Therapy): A specialized biventricular pacemaker that forces the left and right ventricles to contract simultaneously, improving the heart's overall pumping efficiency.
  • LVADs & Transplants: For end-stage heart failure, a Left Ventricular Assist Device (LVAD) can be implanted as a mechanical pump, either as a bridge to a heart transplant or as destination therapy.

🔬 Active Clinical Trials

Current research investigates repurposing existing drugs, analyzing genetic causes, and tracking specialized forms of heart failure like Cardiac Amyloidosis.

  • NCT06053580 (University of Washington): The REVAMP-PH trial investigating the repurposing of Valsartan to protect against pulmonary Hypertension in heart failure.
  • NCT06129656 (University of Leipzig): A large-scale registry studying Cardiac Amyloidosis, an underdiagnosed cause of restrictive heart failure.
  • NCT02432092 (Indiana University): A study focused on pediatric cardiomyopathy mutation analysis to understand the genetic drivers of early-onset heart failure.
Where to look: You can find more recruiting trials via ClinicalTrials.gov or the American Heart Association.

🏃 Cardiac Rehabilitation

While rest was historically prescribed for heart failure, structured exercise is now a Class I recommendation for stable patients.

  • What it is: Cardiac rehab is a medically supervised program designed to improve cardiovascular health through exercise training, education on heart-healthy living, and counseling to reduce stress.
  • Benefits: Regular, tailored exercise improves the efficiency of oxygen use by the muscles, significantly reducing symptoms of fatigue and dyspnea (shortness of breath) during daily activities.
  • Safety: Programs are highly individualized. Vitals (heart rate, blood pressure, ECG) are monitored during exercise to ensure patient safety and to gradually build endurance over time.

❓ Patient FAQ

Q: Can I still exercise with Heart Failure?
A: Yes, and it is highly encouraged! Cardiac rehabilitation programs offer supervised, tailored exercise that can improve your exercise capacity and quality of life. However, always consult your cardiologist before starting a new regimen.

Q: Why do I have to weigh myself every day?
A: A sudden weight gain of 2-3 pounds overnight, or 5 pounds in a week, is usually fluid retention, not fat. It is an early warning sign that your heart failure is worsening, allowing you to contact your doctor and adjust your diuretic dose before you need to be hospitalized.

Back to All 128 CareHub Condition GuidesFor informational purposes only • Always consult a physician